Previous close | 2.4300 |
Open | 2.4300 |
Bid | 2.3500 |
Ask | 4.9000 |
Strike | 2.50 |
Expiry date | 2024-09-20 |
Day's range | 2.4300 - 2.4300 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management will present at the following upcoming investor conferences:
Kodiak (KOD) reports better-than-expected first-quarter 2024 results and provides updates regarding its pipeline development plans.
Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024.